Results 71 to 80 of about 3,329,282 (264)
Public vs physician views of liability for artificial intelligence in health care
Dhruv Khullar +5 more
openalex +2 more sources
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck +12 more
wiley +1 more source
COVID-19 in Spain: a predictable storm?
The Lancet Public Health
doaj +1 more source
[This corrects the article DOI: 10.1371/journal.pgph.0004417.].
PLOS Global Public Health Staff
doaj +1 more source
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Public health policies and health-care workers’ response to the COVID-19 pandemic, Thailand
Natthaprang Nittayasoot +4 more
openalex +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Income, health, and social welfare policies
The Lancet Public Health
doaj +1 more source
[This corrects the article DOI: 10.1371/journal.pgph.0003900.].
PLOS Global Public Health Editors
doaj +1 more source

